5 Results for "

11017

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "11017" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-11017
CAS No.: 129101-54-8
Purity:  99.03%
Synonyms: ENA 713; SDZ-ENA 713
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

Rivastigmine tartrate (ENA 713; SDZ-ENA 713) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM, 4.15 μM, respectively. Rivastigmine tartrate can pass the blood brain barrier (BBB). Rivastigmine tartrate is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease .
loading...
    loading...
Cat. No.: HY-11017AS
CAS No.: 194930-00-2
Purity:  ≥99.0%
(S)-Rivastigmine-d6 (tartrate) is the deuterium labeled (S)-Rivastigmine, which is an cholinesterase inhibitor.
loading...
    loading...
Cat. No.: HY-11017R
CAS No.: 129101-54-8
Synonyms: ENA 713 (Standard); SDZ-ENA 713 (Standard)
Rivastigmine (tartrate) (Standard) is the analytical standard of Rivastigmine (tartrate). This product is intended for research and analytical applications. Rivastigmine tartrate (ENA 713; SDZ-ENA 713) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM, 4.15 μM, respectively. Rivastigmine tartrate can pass the blood brain barrier (BBB). Rivastigmine tartrate is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease .
loading...
    loading...
Cat. No.: HY-P11017
CAS No.: 1152066-26-6
Target:  

p38 MAPK Cadherin

Research Areas:  

Inflammation/Immunology

LNSMGQD is a cyclic peptide fragment derived from desmoglein 1 (amino acids 81-86), which mimics trans-interactions and acts as part of the tandem peptide binding interface of desmoglein 2. LNSMGQD not only binds to desmoglein 1 and 3, but also effectively inhibits their homophilic trans-interactions, while reducing the probability of homophilic or heterophilic binding between desmoglein 2 and Dsc2, N-cadherin and E-cadherin. LNSMGQD is applicable to the research on disease mechanisms such as Crohn's disease and pemphigus vulgaris .
loading...
    loading...
Cat. No.: HY-RS11017
Research Areas:  

Others

PPP2R3C Human Pre-designed siRNA Set A contains three designed siRNAs for PPP2R3C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...